Macrogen

Macrogen Current Assets

The Current Assets of Macrogen (038290.KQ) as of Oct 29, 2026 is 25.38 B KRW. In the previous year, Current Assets was 107.96 B KRW — a change of -76.49% (lower).

Current Assets

25.38 BKRW

YoY

-76.49%

Last updated:

Current Assets of Macrogen is 2025 25.38 B KRW. Current Assets of Macrogen was 2024 107.96 B KRW. It decreases by -76.49% lower compared to the previous year.

The Macrogen Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
128.17 B KRW
Jan 1, 2019
104.06 B KRW
Jan 1, 2020
95.60 B KRW
Jan 1, 2021
98.71 B KRW
Jan 1, 2022
88.49 B KRW
Jan 1, 2023
71.22 B KRW
Jan 1, 2024
107.96 B KRW
Jan 1, 2025
25.38 B KRW
The Macrogen Current Assets history
YEARCurrent AssetsYoY
25.38 BKRW-76.49%
107.96 BKRW+51.60%
71.22 BKRW-19.52%
88.49 BKRW-10.35%
98.71 BKRW+3.26%
95.60 BKRW-8.14%
104.06 BKRW-18.81%
128.17 BKRW+2.89%
124.58 BKRW+30.61%
95.38 BKRW+14.61%
83.22 BKRW+223.37%
25.73 BKRW+42.92%
18.01 BKRW+11.54%
16.14 BKRW+32.61%
12.17 BKRW-43.06%
21.38 BKRW-8.09%
23.26 BKRW+42.57%
16.32 BKRW-2.01%
16.65 BKRW+1.21%
16.45 BKRW+1.79%
16.16 BKRW-1.04%
16.33 BKRW+17.58%
13.89 BKRW-8.36%
15.16 BKRW-14.05%
17.63 BKRW-27.05%
24.17 BKRW-47.31%
45.88 BKRW+16,642.70%
274.00 MKRW+54.80%
177.00 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Macrogen Stock analysis

What does Macrogen do? Macrogen Inc. generates revenue through its four business divisions. The DNA sequencing division provides genome sequencing analysis services to clients requiring genetic data processing. The DNA chips division sells products including Illumina chips, MacArray chips, and customized chips to research institutions and biotech firms. The transgenic and knockout mouse division offers gene engineering services to pharmaceutical companies and academic laboratories. The oligonucleotide DNA division supplies oligonucleotide DNA manufacturing services to biotechnology clients. All services are delivered domestically and internationally to established market segments. The company's DNA chips division markets specific branded products like Illumina chips and MacArray chips, which are purchased by research organizations and biotechnology enterprises. Gene engineering services from the transgenic division are bought by pharmaceutical companies seeking to develop new treatments. Oligonucleotide DNA manufacturing services target biotech clients needing specialized DNA synthesis. Domestic and overseas markets represent the primary customer segments for all divisions. Macrogen's product portfolio includes DNA sequencing services, DNA chip products, gene engineering solutions, and oligonucleotide DNA manufacturing. Clients include research institutions, pharmaceutical companies, academic laboratories, and biotechnology firms. The DNA chips division's branded products are specifically named in the description, while other services are described by their technical functions. Market segments are defined by the company's domestic and international operations. Macrogen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Macrogen stock

Current Assets of Macrogen is 25.38 B KRW in 2025.

Current Assets of Macrogen changed from 107.96 B KRW to 25.38 B KRW, representing a -76.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Macrogen since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Macrogen historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Macrogen

All Key Metrics — Macrogen